Xeris Biopharma Holdings, Inc. (XERS)
NASDAQ: XERS · Real-Time Price · USD
7.18
0.00 (0.00%)
At close: Nov 28, 2025, 1:00 PM EST
7.20
+0.02 (0.28%)
After-hours: Nov 28, 2025, 4:04 PM EST
Xeris Biopharma Holdings Employees
Xeris Biopharma Holdings had 394 employees as of December 31, 2024. The number of employees increased by 17 or 4.51% compared to the previous year.
Employees
394
Change (1Y)
17
Growth (1Y)
4.51%
Revenue / Employee
$675,475
Profits / Employee
-$39,695
Market Cap
1.19B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 394 | 17 | 4.51% |
| Dec 31, 2023 | 377 | 22 | 6.20% |
| Dec 31, 2022 | 355 | 61 | 20.75% |
| Dec 31, 2021 | 294 | 114 | 63.33% |
| Dec 31, 2020 | 180 | -22 | -10.89% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
XERS News
- 23 days ago - Xeris Biopharma Holdings, Inc. (XERS) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 23 days ago - Xeris Biopharma Posts Record Financial Results for the Third Quarter 2025 - Business Wire
- 5 weeks ago - Xeris Biopharma to Report Third Quarter 2025 Financial Results on November 6, 2025 - Business Wire
- 2 months ago - Xeris Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Business Wire
- 3 months ago - Xeris In Recorlev-Fuelled Growth: Why I Choose To Buy - Seeking Alpha
- 3 months ago - Xeris Announces Orange Book Listing of U.S. Patent for Recorlev® - Business Wire
- 4 months ago - Xeris Biopharma Holdings, Inc. (XERS) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 4 months ago - Xeris (XERS) Q2 Revenue Jumps 49% - The Motley Fool